Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2.

Abstract Highly potent CCR3 antagonists have been developed from a previously reported series of phenylalanine ester-based leads. Solution-phase, parallel synthesis optimization was utilized to identify highly potent, functional CCR3 antagonists.